Virus Dataset Sample Info

> Dataset: 31727676 Search Result

Summary

Sample

ID	Sample ID	Age	Detail
1	1-S01	35	View
2	1-S02	30	View
3	1-S03	31	View
4	1-S04	30	View
5	1-S05	28	View
6	1-S06	34	View
7	1-S07	29	View
8	1-S09	23	View
9	1-S10	30	View
10	1-S11	36	View
11	1-S12	31	View
12	1-S13	36	View
13	1-S14	30	View
14	1-S15	27	View
15	1-S16	41	View
16	1-S18	28	View
17	1-S19	45	View
18	1-S20	27	View
19	1-S22	41	View
20	1-S24	23	View
21	1-S25	33	View
22	1-S26	34	View
23	1-S27	25	View
24	1-S28	26	View
25	2-S01	27	View
26	2-S02	46	View
27	2-S03	35	View
28	2-S04	38	View
29	2-S05	33	View
30	2-S06	29	View
31	2-S07	35	View
32	2-S08	33	View
33	2-S09	49	View
34	2-S10	41	View
35	2-S11	35	View
36	2-S12	33	View
37	2-S13	34	View
38	2-S15	35	View
39	2-S16	35	View
40	2-S17	32	View
41	2-S19	26	View
42	2-S20	29	View
43	2-S21	31	View
44	2-S22	28	View
45	2-S23	26	View
46	2-S24	31	View
47	2-S25	30	View
48	2-S26	33	View
49	3-S03	41	View
50	3-S04	35	View
51	3-S05	30	View
52	3-S06	31	View
53	3-S07	28	View
54	3-S09	28	View
55	3-S10	30	View
56	3-S11	24	View
57	3-S12	28	View
58	3-S13	30	View
59	3-S15	27	View
60	3-S16	37	View
61	3-S18	35	View
62	4-S02	40	View
63	4-S03	32	View
64	4-S06	33	View
65	4-S07	34	View
66	4-S08	27	View
67	4-S09	22	View
68	4-S10	34	View
69	4-S11	37	View
70	4-S12	30	View
71	4-S13	32	View
72	4-S14	36	View

Literature

Item	Summary
PMID	31727676
Title	A Phase II, Prospective, Randomized, Multicenter, Open-Label Study of GX-188E, an HPV DNA Vaccine, in Patients with Cervical Intraepithelial Neoplasia 3.
Abstract	PURPOSE: To determine the efficacy of the therapeutic DNA vaccine GX-188E for inducing regression of cervical intraepithelial neoplasia (CIN) 3. PATIENTS AND METHODS: We conducted a prospective, randomized, multicenter, open-label, phase II clinical trial of GX-188E in CIN3 patients positive for human papillomavirus (HPV) type 16/18. The primary endpoint was to determine the histopathologic regression to